Catalyst Pharmaceuticals
CPRX
#3954
Rank
โ‚น274.96 B
Marketcap
โ‚น2,237
Share price
-0.33%
Change (1 day)
24.29%
Change (1 year)

Market capitalization of Catalyst Pharmaceuticals (CPRX)

Market cap: โ‚น274.96 Billion

As of March 2026 Catalyst Pharmaceuticals has a market cap of โ‚น274.96 Billion. This makes Catalyst Pharmaceuticals the world's 3954th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Catalyst Pharmaceuticals from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น274.96 B2.34%
2025โ‚น268.67 B22.3%
2024โ‚น219.68 B47.25%
2023โ‚น149.19 B-6.86%
2022โ‚น160.18 B208.65%
2021โ‚น51.89 B104.72%
2020โ‚น25.35 B-8.32%
2019โ‚น27.65 B100.47%
2018โ‚น13.79 B-46.09%
2017โ‚น25.58 B332.52%
2016โ‚น5.91 B-56.15%
2015โ‚น13.48 B3.68%
2014โ‚น13.01 B99.5%
2013โ‚น6.52 B561.04%
2012โ‚น0.98 B-41.47%
2011โ‚น1.68 B95.92%
2010โ‚น0.86 B63.17%
2009โ‚น0.52 B-56.65%
2008โ‚น1.21 B-28.28%
2007โ‚น1.69 B-36.65%
2006โ‚น2.67 B

End of Day market cap according to different sources

On Mar 8th, 2026 the market cap of Catalyst Pharmaceuticals was reported to be:

โ‚น273.19 Billion
by Nasdaq info icon info icon
โ‚น274.96 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚น53.466 T 19,344.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น14.195 T 5,062.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น17.569 T 6,289.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น161.90 B-41.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
โ‚น75.77 M-99.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น1.084 T 294.54%๐Ÿ‡บ๐Ÿ‡ธ USA